Biblio Discovery — Demo Discovery Service

9 results for "Nicolas Sabarth"

Showing 1–9 · 0.66 seconds · RSS

  1. Journal Article Full text

    H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model.

    M Keith Howard; Nicolas Sabarth; Helga Savidis-Dacho et al.

    PLoS ONE, Vol. 6 No. 8 · 2011 · English · DOAJ Scopus

    Vero cell culture-derived whole-virus H5N1 vaccines have been extensively tested in clinical trials and consistently demonstrated to be safe and immunogenic; however, clinical efficacy is difficult to evaluate in the absence of wide-spread human disease. A lethal mouse model has been utilized which…

    Also available at: PLOS

  2. Journal Article Full text

    Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics

    Patrice Douillard; Michael Freissmuth; Gerhard Antoine et al.

    Antibodies, Vol. 8 No. 3 · 2019 · English · DOAJ Scopus

    Efficacy, safety, and manufacturability of therapeutic antibodies are influenced by their biopharmaceutical and biophysical properties. These properties can be optimized by library approaches or rationale protein design. Here, we employed a protein engineering approach to modify the variable domain…

  3. Journal Article Full text

    A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations

    Annett Hessel; Michael Schwendinger; Daniela Fritz et al.

    PLoS ONE, Vol. 5 No. 8 · 2010 · English · PLOS Scopus

    Background: The development of novel influenza vaccines inducing a broad immune response is an important objective. The aim of this study was to evaluate live vaccines which induce both strong humoral and cell-mediated immune responses against the novel human pandemic H1N1 influenza virus, and to…

    Also available at: DOAJ

  4. Journal Article

    LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager

    Leticia Corrales; Susanne Hipp; Katharina Martin et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    Colorectal cancer (CRC) is one of the most common cancers worldwide and demands more effective treatments. We sought to identify tumor selective CRC antigens and their therapeutic potential for cytotoxic T-cell targeting by transcriptomic and immunohistochemical analysis. LY6G6D was identified as a…

  5. Journal Article

    CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity

    Madhura Modak; Ann-Kathrin Mattes; Daniela Reiss et al.

    JCI Insight, Vol. 7 No. 11 · 2022 · English · DOAJ Scopus

    In many solid cancers, tumor-associated macrophages (TAM) represent the predominant myeloid cell population. Antigen (Ag) cross-presentation leading to tumor Ag–directed cytotoxic CD8+ T cell responses is crucial for antitumor immunity. However, the role of recruited monocyte-derived macrophages…

  6. Journal Article Full text

    A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models

    Otfried Kistner; Brian A. Crowe; Walter Wodal et al.

    PLoS ONE, Vol. 5 No. 2 · 2010 · English · PLOS Scopus

    The recent emergence and rapid spread of a novel swine-derived H1N1 influenza virus has resulted in the first influenza pandemic of this century. Monovalent vaccines have undergone preclinical and clinical development prior to initiation of mass immunization campaigns. We have carried out a series…

    Also available at: DOAJ